US Food and Drug Administration Office of Women's Health: Promoting Therapeutic Optimization in Women.

South, Erin M; Zinn, Rebekah L; Huang, Caroline J; Vasisht, Kaveeta P

South, Erin M; Zinn, Rebekah L; Huang, Caroline J; Vasisht, Kaveeta P.

Afiliación

South EM; Office of Women's Health, Office of the Commissioner, US Food and Drug Administration, Silver Spring, Maryland, USA.
Zinn RL; Office of the Chief Scientist, Office of the Commissioner, US Food and Drug Administration, Silver Spring, Maryland, USA.
Huang CJ; Office of Women's Health, Office of the Commissioner, US Food and Drug Administration, Silver Spring, Maryland, USA.
Vasisht KP; Office of Women's Health, Office of the Commissioner, US Food and Drug Administration, Silver Spring, Maryland, USA.

J Clin Pharmacol ; 60 Suppl 2: S11-S17, 2020 12.

Article en En | MEDLINE | ID: mdl-33274515

Asunto(s)

Salud de la Mujer; Ensayos Clínicos como Asunto; Femenino; Política de Salud; Humanos; Política Organizacional; Factores Sexuales; Estados Unidos; United States Food and Drug Administration

Palabras clave

clinical trials, FDA policy, gender, sex as a biological variable (SABV); sex differences; women's health

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Salud de la Mujer Límite: Female / Humans País/Región como asunto: America do norte Idioma: En Revista: J Clin Pharmacol Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google